Monday, June 22, 2020

Black Lives Matter: Will it lead to reform of Police Forces in the USA?

This article is by

Share this article

Article Contributor(s)

Kanika Bajaj

Article Title

Black Lives Matter: Will it lead to reform of Police Forces in the USA?

Publisher

Global Views 360

Publication Date

June 22, 2020

URL

Police in riot gear

Police in riot gear | Source: AJ Alfieri-Crispin via Wikimedia

The spontaneous eruption of the “Black Lives Matter” protest after the unfortunate death of George Floyd at the hands of Minneapolis police has once again put the spotlight on the operational methodology of the police department at different cities around the USA. There is a chorus across the country, more so in the Democratic Party strongholds to do fundamental reorganization of the police force by focussing on community policing. Some of the extreme and radical activists have gone so far to demand “defund the police” and re-distribute its budget to marginalized communities, municipal corporations and necessity institutions.

“There is no magic switch to turn off and boom there’s no police department,” said Alex Vitale, a sociology professor at Brooklyn College. She released a book named ‘The End of Policing’. The book has become a manifesto for protests and police-reform advocates. The defund development calls for diminishing networks' dependence on police for various administrative problems like, observing the homeless, settling household quarrels, restraining understudies, reacting to upheavals by individuals with mental illness, paring down violence in neighbourhoods, and proportional reaction to minor inconveniences like somebody attempting to pass a fake $20, the allegation that set off the police call that resulted in Floyd's demise. The funds saved by reducing the workload of police could be utilised by social and community workers to resolve street feuds. “When we talk about de-funding the police, what we're saying is invest in the resources that our communities need,” Black Lives Matter co-founder Alicia Garza told NBC News.

There are cities which have approached this reform in a positive manner. New York Mayor Bill de Blasio has decided to shift the money from NYPD budget to youth recreational programs. A whopping $150 million is being pulled out of the LAPD by Los Angeles Mayor Eric Garcetti. This money is proposed to be invested in healthcare systems and build peace centres. Similarly Portland and Oregon have consented to pull police from state funded schools. A few Minneapolis organizations, including the government funded school region, the University of Minnesota and the Park and Recreation Board, have moved to diminish or end their agreements with city police.

Dallas has earlier experienced the positive results of diverting emergency mental health calls, not only on hospitals but also police to non-police establishment when in 2018 RIGHT Care  was provided $3 million funding to look after these issues. Since the program started, ambulances and emergency vehicle calls for individuals encountering emotional wellness inconveniences have declined in the south-local region of Dallas where the program works, which has opened up officials to manage different calls, authorities said. This transition was also done after the outcry over the shooting of a schizophrenic man holding a screwdriver in 2014 and subsequent defence of police personnel by the police boss David Brown.

Law enforcement officials and conservative activists believe that de-funding police would lead to an upsurge in criminal activities. President Donald Trump has started making this as a key plank of his re-election campaign while the Former Vice President Joe Biden, who is running against Trump, also came out against de-funding police.

It is therefore too early to predict whether the current phase of “Black Lives Movement” after the death of George Floyd will be successful in bringing some substantial reform in the working of police forces across the cities of the US or the momentum will be lost with some incremental tweaking here and there.  

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 5:14 PM

Asian countries & the race for COVID-19 Vaccine

Our relationship with the new strain of coronavirus is almost 8 months strong now. Countries like the US, Russia, UK, China, India, and many more have already set their brainy scientists in the task of developing a vaccine, turning it into a race which desperately needs a winner, since no one wants this deadly relationship to endure. Several attempts have proved to be successful, especially in countries like Russia, USA, India, and China.

China was the first to start scouring for a vaccine the day WHO declared that the new strain of SARS-CoV, originating in Wuhan-China, has resulted in a pandemic. It is a fierce competitor, especially to the US, as almost 8 of the 24 promising vaccines approved for clinical trials are from China. It used the technology of ‘inactivated vaccine’ which basically means killing the actual virus and using that to create a vaccine. This method is quite useful in treating measles and influenza, thus, increasing the chances of success in the case of COVID-19 as well.

“It’s a tried and true strategy”, Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said  about the inactivated vaccine. One potential vaccine from China-based Sinopharm is already in the phase 3 of trials whereas Sinovac will enter the third phase this month. Moreover, China has permitted Sinovac and Sinopharm to dilute phase 1 and 2 of vaccine trials on humans to hasten the process.

The head of the Chinese Center for Disease Control and Prevention, Gao Fu, had also been injected with a potential vaccine on July 28, 2020. “I’m going to reveal something undercover: I am injected with one of the vaccines'' Gao Fu said in a webinar hosted by Alibaba Health, an arm of the Chinese e-commerce giant, and Cell Press, an American publisher of scientific journals. However, he did not reveal any more details about how and when exactly he administered himself with the vaccine and ‘hopes’ that the vaccine works.

Vladimir Putin, President of Russia | Source: Wikimedia

Elsewhere in Russia, on August 11, 2020, President Vladimir Putin proudly announced that Russia was the first country to grant regulatory approval to their vaccine after carrying out human trials for less than 2 months by the Gamalei Institute in Moscow. Regulatory approval permits vaccination of the masses. Although it has not undergone phase 3 of trials, Russia expects to initiate mass production of the vaccine by the end of this year. Kirill Dmitriev, head of Russia's sovereign wealth fund states that the vaccine will be called ‘Sputnik V’, named after Sputnik 1, the first satellite launched by Soveit Union which was a euphoric moment for Russia. More recently, China and Russia have joined hands in proceeding with the clinical trials of their vaccines.

These two instances seem to bring a new hope for the future, yet raise alarms and invite scepticism from the experts in the field of public health. One major concern is that without prolonged trials, vaccines should not be authorized for public use. Anthony Fauci, an infectious disease expert based in the US said “I do hope the Chinese and the Russians are actually testing the vaccines before they are administering the vaccine to anyone. Because claims of having a vaccine ready to distribute before you do testing is problematic at the very least”. Hence, some people are still in doubt regarding the safety of the product. Putin, however, rubbished such concerns and said "I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks".

An Indian biotechnological company, Bharat Biotech developed ‘Covaxin’ in collaboration with Indian Council for Medical Research (ICMR), using the mechanism of inactivated vaccine. It was successful in getting approval for human trials which were scheduled to begin in July, 2020. Initial reports stated that it would be ready for mass use by August 15, 2020, which also marked the 73rd Independence Day of India. However, Bharat biotech was clear in letting the public know that phase 1 of the trials are still on-going. ICMR cleared the confusion by stating that it would prepare the results of the phase 1 trials by August 15, 2020, not the actual vaccine for use. Phase 2 of the trials are awaited in September, 2020.

So far, the results of phase 1 trials have been positive as no serious side-effects are observed in the vaccine candidates. “The vaccine has been safe. No adverse effect has been reported. Even the point of injection pain, which is normal in vaccines, has been very mild” said Dr Kushwaha of Prakhar Hospital.

Meanwhile, the South Korean government stated on August 21, 2020, that it will secure adequate vaccine supply to its citizens by cooperating with international bodies and promoting local drug development. Three South Korean companies have started the process of making a vaccine and all are in the clinical trial phase. Bill Gates asserts that the South Korean pharmaceutical company, SK Bioscience, will have around 200 million vaccine doses ready by June 2021.

Japan is jointly collaborating with the UK, France and other European countries to establish a $20 billion fund to buy coronavirus vaccines, with Japan pledging a contribution of $800 million. It’s vaccine program aims to focus on giving primary attention to its medical workers and the elderly people of the country when the first doses of the vaccine are made. The state-funded vaccination program is believed to be officially adopted by Japan in September this year with negotiations with the UK and US based drug makers already in place.

With the race to bring COVID-19 vaccine seemingly coming to a close and it will hopefully be ready by the end of 2020 or early 2021. Till then, the entire world is watching this race with bated breath.

Read More